Everolimus with exemestane for treating advanced breast cancer after endocrine therapy

Technology appraisal guidance
Reference number: TA421
Published: 21 December 2016

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 233 KB)

Published:

23 January 2017

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 339 KB)

Published:

11 November 2016
Committee papers (PDF 726 KB)

Published:

11 November 2016

Draft guidance: 1

Draft guidance: 1
Appraisal consultation document (PDF 325 KB)

Published:

18 August 2016
Committee papers (PDF 2.16 MB)

Published:

19 August 2016